Sang‐Won Park
- Geriatrics and Gerontology top 0.5%
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 10
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research 24
- Antimicrobial Resistance in Staphylococcus 20
- COVID-19 Clinical Research Studies 19
- HIV/AIDS drug development and treatment 10
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 28
-
- Pneumonia and Respiratory Infections 11
-
- Infectious Diseases and Tuberculosis 10
- Co-authors
- Nam‐Gyu ParkChang-Ryul LeeJin‐Wook LeeJeong‐Hyeok ImMyoung‐don OhHong Bin KimStephen B. KritchevskyBret H. Goodpaster
- Journals
- Journal of Korean Medical Science (25 papers)BMC Infectious Diseases (10 papers)Antimicrobial Agents and Chemotherapy (9 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Sang‐Won Park
266 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 190
- Applied Microbiology and Biotechnology 332
- Geriatrics and Gerontology 425
- Molecular Medicine 527
- Infectious Diseases 1.9k
- Clinical Biochemistry 676
Countries citing papers authored by Sang‐Won Park
This map shows the geographic impact of Sang‐Won Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Won Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Won Park more than expected).
Fields of papers citing papers by Sang‐Won Park
This network shows the impact of papers produced by Sang‐Won Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Won Park. The network helps show where Sang‐Won Park may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sang‐Won Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 25 | |
| 8 | 2019 | 6 | |
| 9 | 2016 | 156 | |
| 10 | 2011 | 101 | |
| 11 | 2009 | 2 | |
| 12 | 2006 | 55 | |
| 13 | 2005 | 0 | |
| 14 | 2003 | 7 | |
| 15 | 2001 | 0 | |
| 16 | 2000 | 1 | |
| 17 | 1998 | 1 | |
| 18 | 1995 | 1 | |
| 19 | 1995 | 1 | |
| 20 | 1991 | 2 |
About Sang‐Won Park
Sang‐Won Park is a scholar working on Infectious Diseases, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 288 papers that have together received 10.4k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (28 papers), SARS-CoV-2 and COVID-19 Research (24 papers), Antimicrobial Resistance in Staphylococcus (20 papers), COVID-19 Clinical Research Studies (19 papers), Pneumonia and Respiratory Infections (11 papers), Antibiotic Resistance in Bacteria (10 papers), HIV/AIDS drug development and treatment (10 papers) and Infectious Diseases and Tuberculosis (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (332 citations), Geriatrics and Gerontology (425 citations) and Molecular Medicine (527 citations). Sang‐Won Park has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Nam‐Gyu Park, Chang-Ryul Lee, Jin‐Wook Lee, Jeong‐Hyeok Im, Myoung‐don Oh, Hong Bin Kim, Stephen B. Kritchevsky, Bret H. Goodpaster, T. B. Harris and Marjolein Visser. Their work appears in journals such as Journal of Korean Medical Science, BMC Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.